---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-002326"
form_type: "8-K"
ticker: "ASBP"
cik: "0001847345"
company_name: "Aspire Biopharma Holdings, Inc."
filed_at: "2026-01-15T23:59:59+00:00"
generated_at: "2026-05-16T10:12:17.927935+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Aspire Biopharma Board sets share limit for 2024 Stock Incentive Plan at 4,890,000 shares

## Summary
- Board confirmed share limit of 4,890,000 shares for the 2024 Stock Incentive Plan, which was approved by stockholders in Feb 2025.
- Approved forms of Restricted Stock Unit and Stock Option award agreements under the Plan.
- Plan allows grants of equity awards to employees, directors, and consultants to align with long-term stockholder interests.

## SEC filing metadata
- accession: 0001493152-26-002326
- form_type: 8-K
- ticker: ASBP
- cik: 0001847345
- company_name: Aspire Biopharma Holdings, Inc.
- filed_at: 2026-01-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847345/000149315226002326/0001493152-26-002326-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847345/000149315226002326/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-002326
- JSON: https://secwatch.observer/filing/0001493152-26-002326.json
- Plain text: https://secwatch.observer/filing/0001493152-26-002326.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.